Search Results - "Gale, Jeremy D"

Refine Results
  1. 1

    A CCR2/5 Inhibitor, PF-04634817, Is Inferior to Monthly Ranibizumab in the Treatment of Diabetic Macular Edema by Gale, Jeremy D, Berger, Brian, Gilbert, Steven, Popa, Serghei, Sultan, Marla B, Schachar, Ronald A, Girgenti, Douglas, Perros-Huguet, Christelle

    “…Ligands for the proinflammatory C-C chemokine receptor types 2 and 5 (CCR2 and CCR5) are elevated in the eyes of patients with diabetic macular edema (DME). We…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Advantages of a wholly Bayesian approach to assessing efficacy in early drug development: a case study by Walley, Rosalind J., Smith, Claire L., Gale, Jeremy D., Woodward, Phil

    “…This paper illustrates how the design and statistical analysis of the primary endpoint of a proof‐of‐concept study can be formulated within a Bayesian…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Pregabalin inhibits accelerated defecation and decreased colonic nociceptive threshold in sensitized rats by Ohashi-Doi, Katsuyo, Gale, Jeremy D., Kurebayashi, Yoichi

    Published in European journal of pharmacology (15-09-2010)
    “…Pregabalin, a ligand of α 2δ subunits of voltage-gated calcium channels, reduces visceral hypersensitivity associated with irritable bowel syndrome. However,…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9

    Alternative Endoscopy Reading Paradigms Determine Score Reliability and Effect Size in Ulcerative Colitis by Reinisch, Walter, Pradhan, Vivek, Ahmad, Saira, Zhang, Zhen, Gale, Jeremy D

    Published in Journal of Crohn's and colitis (27-01-2024)
    “…Central reading of endoscopy is advocated by regulatory agencies for clinical trials in ulcerative colitis [UC]. It is uncertain whether the local/site reader…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12

    Biomarkers of Crohn’s Disease to Support the Development of New Therapeutic Interventions by Porter, Amy C, Aubrecht, Jiri, Birch, Chandler, Braun, Jonathan, Cuff, Carolyn, Dasgupta, Suryasarathi, Gale, Jeremy D, Hinton, Robert, Hoffmann, Steven C, Honig, Gerard, Linggi, Bryan, Schito, Marco, Casteele, Niels Vande, Sauer, John-Michael

    Published in Inflammatory bowel diseases (01-10-2020)
    “…Abstract Background Currently, 2 coprimary end points are used by health authorities to determine the effectiveness of therapeutic interventions in patients…”
    Get full text
    Journal Article
  13. 13

    Histological sub‐classification of cirrhosis using collagen proportionate area in patients with chronic hepatitis C by Papatheodoridi, Margarita, Hall, Andrew R., Rodríguez‐Perálvarez, Manuel, Pieri, Giulia, Germani, Giacomo, Gale, Jeremy D., Burgess, Gary C., Pinzani, Massimo, Dhillon, Amar P., Tsochatzis, Emmanuel A.

    Published in Liver international (01-07-2021)
    “…Collagen proportionate area (CPA, %) is used to quantify liver fibrosis. Here, we assessed CPA performance to sub‐classify cirrhosis. CPA was measured in…”
    Get full text
    Journal Article
  14. 14

    Effect of PF-04634817, an Oral CCR2/5 Chemokine Receptor Antagonist, on Albuminuria in Adults with Overt Diabetic Nephropathy by Gale, Jeremy D, Gilbert, Steven, Blumenthal, Samuel, Elliott, Tom, Pergola, Pablo E, Goteti, Kosalaram, Scheele, Wim, Perros-Huguet, Christelle

    Published in Kidney international reports (01-11-2018)
    “…Inflammatory cell recruitment, which is potentially mediated by the monocyte chemoattractant protein 1/C-C chemokine receptor type 2 (CCR2) system and by C-C…”
    Get full text
    Journal Article
  15. 15

    The use of novel promotility and prosecretory agents for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation by Gale, Jeremy D.

    Published in Advances in therapy (01-05-2009)
    “…Chronic idiopathic constipation (CIC) and irritable bowel syndrome with constipation (C-IBS) are commonly reported gastrointestinal (GI) disorders that have a…”
    Get full text
    Journal Article
  16. 16

    Alpha 2 Delta (α(2)δ) Ligands, Gabapentin and Pregabalin: What is the Evidence for Potential Use of These Ligands in Irritable Bowel Syndrome by Gale, Jeremy D, Houghton, Lesley A

    Published in Frontiers in pharmacology (2011)
    “…Irritable bowel syndrome (IBS) is a complex disorder that is characterized by abdominal pain and altered bowel habit, and often associates with other…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Evidence for functional ghrelin receptors on parasympathetic preganglionic neurons of micturition control pathways in the rat by Ferens, Dorota M, Yin, Lei, Ohashi-Doi, Katsuyo, Habgood, Mark, Bron, Romke, Brock, James A, Gale, Jeremy D, Furness, John B

    “…Summary 1. Previous work indicates that agonists of ghrelin receptors can act within the spinal cord to stimulate autonomic outputs to the colorectum and to…”
    Get full text
    Journal Article
  19. 19
  20. 20